00000000|MMI|149.02|Ivory Coast|C0022326|[geoa]|["IV"-tx-18-"IV"-noun-0,"IV"-tx-17-"IV"-noun-0,"IV"-tx-16-"IV"-noun-0,"IV"-tx-14-"IV"-noun-0,"IV"-tx-9-"IV"-noun-0,"IV"-tx-8-"IV"-noun-0,"IV"-tx-2-"IV"-noun-0]|TX|3438/2;3313/2;3191/2;2934/2;2686/2;[2540/2],[2589/2];642/2|Z01.058.290.190.272
00000000|MMI|125.80|Dominican Republic|C0013014|[geoa]|["DR"-tx-20-"Dr"-noun-0,"DR"-tx-19-"Dr"-noun-0,"DR"-tx-18-"Dr"-noun-0,"DR"-tx-16-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|3587/2;3540/2;3487/2;3265/2;1605/2;1556/2;1509/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|105.67|Cellulitis|C0007642|[patf]|["CELLULITIS"-tx-8-"cellulitis"-noun-0,"CELLULITIS"-tx-1-"cellulitis"-noun-0]|TX|[1726/10],[1832/10],[2064/10],[2399/10],[2494/10];64/10|C01.539.800.130;C01.539.830.200;C17.300.185;C23.550.470.756.200
00000000|MMI|101.70|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-23-"DISCHARGE"-noun-0,"Discharge"-tx-18-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|3721/9;3371/9;1763/9;175/9;262/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|101.25|Physicians|C0031831|[prog]|["DR"-tx-20-"Dr"-noun-0,"DR"-tx-19-"Dr"-noun-0,"DR"-tx-18-"Dr"-noun-0,"DR"-tx-16-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|3587/2;3540/2;3487/2;3265/2;1605/2;1556/2;1509/2|M01.526.485.810;N02.360.810
00000000|MMI|87.43|Imipenem|C0020933|[antb,orch]|["IMIPENEM"-tx-5-"IMIPENEM"-noun-0,"IMIPENEM"-tx-2-"IMIPENEM"-noun-0]|TX|[936/8],[984/8];615/8|D02.065.589.099.124.300.500;D04.075.080.875.099.221.124.300.500
00000000|MMI|84.93|Togo|C0040363|[geoa]|["TO"-tx-20-"To"-adv-0,"TO"-tx-19-"To"-adv-0,"TO"-tx-18-"To"-adv-0,"TO"-tx-16-"to"-adv-0,"TO"-tx-5-"TO"-adv-0]|TX|3566/2;3516/2;3461/2;3175/2;1453/2|Z01.058.290.190.800
00000000|MMI|84.93|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-20-"To"-adv-0,"TO"-tx-19-"To"-adv-0,"TO"-tx-18-"To"-adv-0,"TO"-tx-16-"to"-adv-0,"TO"-tx-5-"TO"-adv-0]|TX|3566/2;3516/2;3461/2;3175/2;1453/2|D08.811.520.224.800
00000000|MMI|68.77|Antibiotics, Antitubercular|C0003237|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|D27.505.954.122.085.255.135
00000000|MMI|61.19|Obesity|C0028754|[dsyn]|["OBESITY"-tx-8-"obesity"-noun-0]|TX|[2021/7],[2031/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|49.55|Antibiotics|C0003232|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|D27.505.954.122.085
00000000|MMI|49.28|Omeprazole|C0028978|[orch,phsu]|["OMEPRAZOLE"-tx-5-"OMEPRAZOLE"-noun-0]|TX|[1179/10],[1301/10],[1361/10]|D02.886.640.074.500;D03.383.725.024.500;D03.438.103.034.500
00000000|MMI|49.20|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-5-"GLYBURIDE"-noun-0,"GLYBURIDE"-tx-2-"GLYBURIDE"-noun-0]|TX|[1285/9],[1345/9];567/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-8-"DIAGNOSIS"-noun-0]|TX|[1715/9],[1865/9]|x.x.x.x.x.x.x
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|420/4;438/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|43.44|Patients|C0030705|[podg]|["*^patient"-tx-16-"Patient"-noun-0,"*^patient"-tx-15-"Patient"-noun-0,"*^patient"-tx-11-"Patient"-noun-0,"*^patient"-tx-9-"patient"-noun-0,"*^patient"-tx-8-"patient"-noun-0,"*^patient"-tx-5-"Patient"-noun-0]|TX|3167/7;2975/7;2795/7;2670/7;2437/7;1393/7|M01.643
00000000|MMI|40.33|Portugal|C0032729|[geoa]|["PO"-tx-8-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2644/2;[1082/2],[1198/2];528/2|Z01.542.727
00000000|MMI|39.69|Osteomyelitis|C0029443|[dsyn]|["OSTEOMYELITIS"-tx-8-"osteomyelitis"-noun-0,"OSTEOMYELITIS"-tx-1-"osteomyelitis"-noun-0]|TX|[1739/13],[1845/13];77/13|C01.539.160.495;C05.116.165.495
00000000|MMI|38.88|District of Columbia|C0012764|[geoa]|["D.C."-tx-5-"D/C"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|1468/3;336/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|36.25|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-8-"ALLERGY"-noun-0,"ALLERGY"-tx-5-"ALLERGY"-noun-0,"Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|1637/7;[906/7],[954/7];[919/11],[967/11]|C20.543
00000000|MMI|35.81|Mitral Valve Prolapse Syndrome|C0026267|[dsyn]|["MITRAL VALVE PROLAPSE"-tx-8-"mitral valve prolapse"-noun-0,"Mitral prolapse"-tx-8-"mitral prolapse"-noun-0]|TX|2095/21;2077/15|C14.280.484.400.500
00000000|MMI|32.34|Ankle brachial pressure index (observable entity)|C1328319|[clna]|["ABI"-tx-15-"ABI"-noun-0,"ABI"-tx-8-"ABI"-noun-0]|TX|3032/3;2261/3|E01.370.370.140.049
00000000|MMI|32.28|Lebanon|C0023190|[geoa]|["LE"-tx-8-"LE"-noun-0]|TX|[2413/2],[2491/2]|Z01.252.245.500.450
00000000|MMI|32.26|Fluorides|C0016327|[inch,phsu]|["F-"-tx-16-"f"-noun-0,"F-"-tx-11-"F"-noun-0]|TX|3219/1;2845/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|30.42|Aspirin|C0004057|[orch,phsu]|["ASPIRIN"-tx-2-"ASPIRIN"-noun-0]|TX|504/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|30.42|Obesity, Morbid|C0028756|[dsyn]|["Morbid Obesity"-tx-8-"morbid obesity"-noun-0]|TX|2351/14|C18.654.726.500.700;C23.888.144.699.500.500;E01.370.600.115.100.160.120.699.500.500;G07.100.100.160.120.699.500.500
00000000|MMI|30.30|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-8-"ALLERGY"-noun-0,"Allergy"-tx-5-"ALLERGY"-noun-0]|TX|1637/7;[906/7],[954/7]|H02.403.044
00000000|MMI|29.46|Urinary tract infection|C0042029|[dsyn]|["URINARY TRACT INFECTION"-tx-8-"urinary tract infection"-noun-0,"UTI"-tx-8-"uti"-noun-0]|TX|2125/23;2119/3|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|27.59|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-20-"Dr"-noun-0,"DR"-tx-19-"Dr"-noun-0,"DR"-tx-18-"Dr"-noun-0,"DR"-tx-16-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|3587/2;3540/2;3487/2;3265/2;1605/2;1556/2;1509/2|
00000000|MMI|27.59|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-20-"Dr"-noun-0,"DR"-tx-19-"Dr"-noun-0,"DR"-tx-18-"Dr"-noun-0,"DR"-tx-16-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|3587/2;3540/2;3487/2;3265/2;1605/2;1556/2;1509/2|
00000000|MMI|27.59|Doctor - Title|C2348314|[cnce]|["Dr."-tx-20-"Dr"-noun-0,"Dr."-tx-19-"Dr"-noun-0,"Dr."-tx-18-"Dr"-noun-0,"Dr."-tx-16-"Dr"-noun-0,"Dr."-tx-7-"Dr"-noun-0,"Dr."-tx-6-"Dr"-noun-0,"Dr."-tx-5-"Dr"-noun-0]|TX|3587/2;3540/2;3487/2;3265/2;1605/2;1556/2;1509/2|
00000000|MMI|26.64|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-8-"diabetes mellitus"-noun-0,"Diabetes"-tx-8-"diabetes"-noun-0]|TX|1953/17;1942/8|C18.452.394.750;C19.246
00000000|MMI|26.19|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-5-"D/C"-noun-0,"D & C"-tx-1-"D/C"-noun-0]|TX|1468/3;336/3|E04.157.310;E04.950.300.299
00000000|MMI|26.15|PO-2|C0297199|[orch]|["PO-2"-tx-5-"PO 2"-noun-0,"PO-2"-tx-2-"PO 2"-noun-0]|TX|1082/2,1104/1;561/2,577/1|x.x.x.x
00000000|MMI|26.09|Pulmonary Vascular Resistance|C0456261|[fndg]|["PVR"-tx-15-"PVR"-noun-0,"PVR"-tx-8-"PVRs"-noun-1]|TX|3036/3;2265/4|G09.330.380.921
00000000|MMI|25.99|Mongolia|C0026410|[geoa]|["MG"-tx-5-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|1195/2;525/2|Z01.252.474.651
00000000|MMI|25.65|Ancef|C0700926|[antb,orch]|["Ancef"-tx-8-"Ancef"-noun-0]|TX|2592/5|D02.065.589.099.249.160;D02.886.665.074.160;D04.075.080.875.099.221.249.160
00000000|MMI|24.77|Override|C1547671|[acty]|["Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"overridden"-noun-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-3-"Override"-verb-0,"Override"-tx-3-"overridden"-noun-0]|TX|1222/8;1210/10;[1004/8],[1383/8];841/8;829/10|
00000000|MMI|24.11|Cephalosporins|C3536856|[antb,orch]|["CEPHALOSPORINS"-tx-8-"Cephalosporins"-noun-0]|TX|1660/14|D02.065.589.099.249;D02.886.665.074;D04.075.080.875.099.221.249
00000000|MMI|24.11|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-8-"Penicillins"-noun-0]|TX|1646/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2184/10|x.x.x.x.x.x.x
00000000|MMI|23.12|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-8-"htn"-noun-0,"HYPERTENSION"-tx-8-"hypertension"-noun-0]|TX|1973/3;1979/12|C14.907.489
00000000|MMI|23.06|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-15-"Patient"-noun-0,"Patient"-tx-11-"Patient"-noun-0,"Patient"-tx-9-"patient"-noun-0,"Patient"-tx-8-"patient"-noun-0,"Patient"-tx-5-"Patient"-noun-0]|TX|3167/7;2975/7;2795/7;2670/7;2437/7;1393/7|
00000000|MMI|23.06|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-15-"Patient"-noun-0,"Patient"-tx-11-"Patient"-noun-0,"Patient"-tx-9-"patient"-noun-0,"Patient"-tx-8-"patient"-noun-0,"Patient"-tx-5-"Patient"-noun-0]|TX|3167/7;2975/7;2795/7;2670/7;2437/7;1393/7|
00000000|MMI|23.06|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-15-"Patient"-noun-0,"Patient"-tx-11-"Patient"-noun-0,"Patient"-tx-9-"patient"-noun-0,"Patient"-tx-8-"patient"-noun-0,"Patient"-tx-5-"Patient"-noun-0]|TX|3167/7;2975/7;2795/7;2670/7;2437/7;1393/7|
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|x.x.x.x.x.x.x
00000000|MMI|22.37|Cilastatin|C0008777|[orch,phsu]|["CILASTATIN"-tx-2-"CILASTATIN"-noun-0]|TX|624/10|D02.455.426.392.368.533.200;D10.251.355.325.200
00000000|MMI|21.36|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0,"Diagnosed"-tx-8-"diagnosed"-verb-0]|TX|[1715/9],[1865/9];[2560/9],[2620/9]|E01
00000000|MMI|21.36|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-22-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|3679/3;892/3;818/3;415/3|
00000000|MMI|20.95|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-2-"FUROSEMIDE"-noun-0]|TX|542/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|20.69|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-8-"ALLERGY"-noun-0,"Allergy"-tx-5-"ALLERGY"-noun-0]|TX|1637/7;[906/7],[954/7]|C20.543
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-18-"CONDITION"-noun-0,"condition"-tx-8-"Conditions"-noun-0]|TX|3381/9;1875/10|C23.550.288
00000000|MMI|20.09|Ambulatory Care Facilities|C0002424|[hcro,mnob]|["Clinic"-tx-16-"clinic"-noun-0]|TX|[3234/6],[3246/6]|N02.278.035
00000000|MMI|20.01|Erythema|C0041834|[dsyn]|["ERYTHEMA"-tx-15-"erythema"-noun-0,"ERYTHEMA"-tx-10-"Erythema"-noun-0]|TX|3088/8;2725/8|C17.800.229
00000000|MMI|19.75|Proliferative vitreoretinopathy|C0242852|[dsyn]|["PVR"-tx-15-"PVR"-noun-0,"PVR"-tx-8-"PVRs"-noun-1]|TX|3036/3;2265/4|C11.768.890
00000000|MMI|19.38|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-2-"LASIX"-noun-0]|TX|534/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|18.65|To|C1883351|[qlco]|["To"-tx-20-"To"-adv-0,"To"-tx-19-"To"-adv-0,"To"-tx-18-"To"-adv-0,"To"-tx-16-"to"-adv-0,"To"-tx-5-"TO"-adv-0]|TX|3566/2;3516/2;3461/2;3175/2;1453/2|
00000000|MMI|17.80|Fluoroquinolones|C0949665|[orch,phsu]|["Fluoroquinolones"-tx-8-"Fluoroquinolones"-noun-0]|TX|1677/16|D03.438.810.835.322
00000000|MMI|16.30|Prilosec|C0700777|[orch,phsu]|["PriLOSEC"-tx-5-"PRILOSEC"-noun-0]|TX|1168/8|D02.886.640.074.500;D03.383.725.024.500;D03.438.103.034.500
00000000|MMI|16.22|Dizziness|C0012833|[sosy]|["DIZZY"-tx-12-"dizzy"-adj-1]|TX|2884/5|C10.597.751.237;C23.888.592.763.237
00000000|MMI|16.22|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["NIDDM"-tx-8-"NIDDM"-noun-0]|TX|2320/5|C18.452.394.750.149;C19.246.300
00000000|MMI|16.19|Order (action)|C1705178|[acty]|["Order"-tx-23-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.19|Order (arrangement)|C1705176|[qlco]|["Order"-tx-23-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.19|Order (document)|C1705175|[inpr]|["Order"-tx-23-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.19|Order (taxonomic)|C1705177|[clas]|["Order"-tx-23-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.19|Permutation|C1882348|[qlco]|["Order"-tx-23-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.19|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-23-"ORDERS"-verb-0,"ORDER"-tx-2-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|3731/6;750/5;340/5;185/6|
00000000|MMI|16.14|skilled nursing facility|C0037265|[hcro,mnob]|["Skilled Nursing Facility"-tx-2-"Skilled Nursing Facility"-noun-0]|TX|456/24|N02.278.825.610.770
00000000|MMI|16.08|Dysuria|C0013428|[sosy]|["DYSURIA"-tx-12-"dysuria"-noun-1]|TX|2867/7|C23.888.942.343.274
00000000|MMI|16.07|Tonga (Geographic Area)|C0040407|[geoa]|["TON"-tx-1-"Tons"-noun-0]|TX|234/4|Z01.639.760.815.890
00000000|MMI|16.07|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-2-"SC"-noun-0]|TX|608/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|14.76|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-23-"DISCHARGE"-noun-0,"Discharge"-tx-18-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3721/9;3371/9;1763/9;175/9|
00000000|MMI|14.76|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-23-"DISCHARGE"-noun-0,"Discharge"-tx-18-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3721/9;3371/9;1763/9;175/9|
00000000|MMI|14.64|Buffers|C0006353|[irda,phsu]|["Buffered"-tx-2-"BUFFERED"-verb-0]|TX|512/8|D27.720.470.280
00000000|MMI|14.64|Consultation|C0009818|[hlca]|["consulted"-tx-14-"consulted"-verb-0]|TX|2920/9|N04.452.758.849
00000000|MMI|14.64|Dermatitis, Atopic|C0011615|[dsyn]|["ATOPIC DERMATITIS"-tx-8-"atopic dermatitis"-noun-0]|TX|2151/17|C16.320.850.210;C17.800.174.193;C17.800.815.193;C17.800.827.210;C20.543.480.343
00000000|MMI|14.64|Diet|C0012155|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|1415/4|G07.203.650.240
00000000|MMI|14.64|Eczema|C0013595|[dsyn]|["Atopic Dermatitis"-tx-8-"atopic dermatitis"-noun-0]|TX|2151/17|C17.800.174.620;C17.800.815.620
00000000|MMI|14.64|Quinolones|C0034428|[orch]|["Quinolones"-tx-8-"quinolones"-noun-0]|TX|1696/10|D03.438.810.835
00000000|MMI|14.64|urinastatin|C0077906|[aapp,phsu]|["UTI"-tx-8-"uti"-noun-0]|TX|2119/3|x.x.x.x
00000000|MMI|14.61|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-20-"follow up"-adj-0,"FOLLOW-UP"-tx-19-"follow up"-adj-0,"FOLLOW-UP"-tx-18-"follow up"-adj-0,"FOLLOW-UP"-tx-5-"FOLLOW UP"-adj-0]|TX|3569/9;3519/9;3464/9;1481/9|
00000000|MMI|14.61|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-20-"follow up"-adj-0,"Follow-Up"-tx-19-"follow up"-adj-0,"Follow-Up"-tx-18-"follow up"-adj-0,"Follow-Up"-tx-5-"FOLLOW UP"-adj-0]|TX|3569/9;3519/9;3464/9;1481/9|
00000000|MMI|14.61|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-20-"follow up"-adj-0,"Follow-up"-tx-19-"follow up"-adj-0,"Follow-up"-tx-18-"follow up"-adj-0,"Follow-up"-tx-5-"FOLLOW UP"-adj-0]|TX|3569/9;3519/9;3464/9;1481/9|
00000000|MMI|14.61|follow-up|C1522577|[hlca]|["Follow Up"-tx-20-"follow up"-adj-0,"Follow Up"-tx-19-"follow up"-adj-0,"Follow Up"-tx-18-"follow up"-adj-0,"Follow Up"-tx-5-"FOLLOW UP"-adj-0]|TX|3569/9;3519/9;3464/9;1481/9|
00000000|MMI|14.59|10%|C3842590|[fndg]|["10%"-tx-23-"10"-fraction-0,"10%"-tx-8-"10"-fraction-0,"10%"-tx-7-"10"-fraction-0,"10%"-tx-1-"10"-fraction-0]|TX|3693/2;2630/2;1584/2;284/2|
00000000|MMI|14.55|Identifier|C0600091|[inpr]|["ID"-tx-20-"ID"-noun-0,"ID"-tx-16-"ID"-noun-0,"ID"-tx-14-"ID"-noun-0,"ID"-tx-7-"ID"-noun-0]|TX|3584/2;3243/2;2917/2;1581/2|
00000000|MMI|14.55|Immune diffusion|C1441613|[lbpr]|["ID"-tx-20-"ID"-noun-0,"ID"-tx-16-"ID"-noun-0,"ID"-tx-14-"ID"-noun-0,"ID"-tx-7-"ID"-noun-0]|TX|3584/2;3243/2;2917/2;1581/2|
00000000|MMI|14.50|Additional|C1524062|[ftcn]|["Additional"-tx-17-"additional"-adj-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-3-"added"-verb-0,"Additional"-tx-2-"additional"-adj-0]|TX|3335/10;1231/5;850/5;710/10|
00000000|MMI|14.42|SNF|C1548534|[spco]|["SNF"-tx-18-"SNF"-noun-0,"SNF"-tx-16-"SNF"-noun-0,"SNF"-tx-5-"SNF"-noun-0,"SNF"-tx-1-"SNF"-noun-0]|TX|3420/3;3184/3;1477/3;321/3|
00000000|MMI|14.35|Daily|C0332173|[tmco]|["QD"-tx-5-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|[1085/2],[1201/2];[531/2],[564/2]|
00000000|MMI|14.33|Oral|C0442027|[spco]|["PO"-tx-8-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|2644/2;[1082/2],[1198/2];528/2|
00000000|MMI|13.09|Foot|C0016504|[bpoc]|["FOOT"-tx-15-"foot"-noun-0]|TX|3146/4|A01.378.610.250
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-18-"PLAN"-noun-0]|TX|3405/4|C10.228.140.744
00000000|MMI|13.05|Heparin|C0019134|[bacs,orch,phsu]|["HEPARIN"-tx-2-"HEPARIN"-noun-0]|TX|590/7|D09.698.373.400
00000000|MMI|13.03|Rabbi|C0684010|[prog]|["R."-tx-8-"R"-noun-0]|TX|2250/1|M01.526.799.500
00000000|MMI|12.95|PO-1|C0297198|[orch]|["PO-1"-tx-5-"PO 1"-noun-0]|TX|1082/2,1112/1|x.x.x.x
00000000|MMI|12.92|Diarrhea|C0011991|[sosy]|["DIARRHOEA"-tx-12-"diarrhea"-noun-1]|TX|2875/8|C23.888.821.214
00000000|MMI|12.92|Dyspnea|C0013404|[sosy]|["SOB"-tx-12-"SOB"-noun-1]|TX|2863/3|C08.618.326;C23.888.852.371
00000000|MMI|12.91|Prempro|C0722753|[orch,phsu]|["Prempro"-tx-5-"PREMPRO"-noun-0]|TX|1088/7|x.x.x.x
00000000|MMI|12.90|Awareness|C0004448|[menp]|["Aware"-tx-5-"aware"-adj-0]|TX|1014/5|F02.463.188.150
00000000|MMI|12.90|Rehabilitation therapy|C0034991|[topp]|["Rehab"-tx-1-"rehab"-noun-0]|TX|325/5|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-8-"Complications"-noun-0]|TX|1901/13|x.x.x
00000000|MMI|11.49|Dermatitis|C0011603|[dsyn]|["DERMATITIS"-tx-8-"dermatitis"-noun-0]|TX|2171/10|C17.800.174
00000000|MMI|11.49|Diet therapy|C0012159|[hlca]|["Diet"-tx-5-"DIET"-noun-0]|TX|1415/4|E02.642.249
00000000|MMI|11.49|Edema|C0013604|[fndg]|["OEDEMA"-tx-8-"edema"-noun-0]|TX|1994/5|C23.888.277
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2199/10|x.x.x
00000000|MMI|11.15|Continuous|C0549178|[idcn]|["Continue"-tx-17-"continue"-verb-0,"Continued"-tx-15-"continued"-verb-0,"Continue"-tx-2-"continue"-verb-0]|TX|3304/8;3054/9;694/8|
00000000|MMI|11.10|Antibiotic throat preparations|C3540706|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C3540707|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|Antibiotics for systemic use|C3540704|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|Antibiotics, Gynecological|C3540708|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|Antibiotics, ophthalmologic|C3540710|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|Antifungal Antibiotics, Topical|C3540705|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.10|antibiotics, intestinal|C3540709|[antb]|["Antibiotics"-tx-17-"antibiotics"-noun-0,"Antibiotics"-tx-15-"antibiotics"-noun-0,"Antibiotics"-tx-8-"antibiotics"-noun-0]|TX|3316/11;3042/11;2470/11|
00000000|MMI|11.08|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-8-"ALLERGY"-noun-0,"Allergy"-tx-5-"ALLERGY"-noun-0]|TX|1637/7;[906/7],[954/7]|
00000000|MMI|11.08|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-8-"ALLERGY"-noun-0,"Allergy"-tx-5-"ALLERGY"-noun-0]|TX|1637/7;[906/7],[954/7]|
00000000|MMI|11.08|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-8-"ALLERGY"-noun-0,"ALLERGY"-tx-5-"ALLERGY"-noun-0]|TX|1637/7;[906/7],[954/7]|
00000000|MMI|10.91|Peripherally inserted central catheter (physical object)|C0179740|[medd]|["picc"-tx-18-"PICC"-noun-0,"picc"-tx-9-"PICC"-noun-0,"picc"-tx-8-"PICC"-noun-0]|TX|3429/4;2702/4;2603/4|
00000000|MMI|10.87|Beginning|C0439659|[tmco]|["Start"-tx-8-"starting"-verb-0,"Start"-tx-2-"Starting"-adj-0]|TX|[2422/8],[2507/8];649/8|
00000000|MMI|10.73|Discontinued|C1444662|[fndg]|["D/C"-tx-5-"D/C"-noun-0,"D/C"-tx-1-"D/C"-noun-0,"DIS"-tx-1-"DIS"-noun-0]|TX|1468/3;336/3;95/3|
00000000|MMI|10.65|20%|C3842589|[fndg]|["20%"-tx-7-"20"-fraction-0,"20%"-tx-5-"20"-integer-0,"20%"-tx-2-"20"-integer-0]|TX|1587/2;1192/2;555/2|
00000000|MMI|10.55|Primary|C0205225|[qlco]|["Primary"-tx-18-"primary"-adj-0,"Primary"-tx-16-"primary"-adj-0,"Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|3479/7;3257/7;1753/9|
00000000|MMI|10.54|Ortho-|C0812371|[idcn]|["Ortho"-tx-19-"Ortho"-adj-0,"Ortho"-tx-16-"Ortho"-adj-0,"Ortho"-tx-6-"ortho"-adj-0]|TX|3534/5;3228/5;1530/5|
00000000|MMI|10.53|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-8-"scheduled"-adj-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-adj-0]|TX|1625/9;1593/9;1544/9|
00000000|MMI|10.53|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-8-"scheduled"-adj-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-adj-0]|TX|1625/9;1593/9;1544/9|
00000000|MMI|10.53|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-8-"scheduled"-adj-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-adj-0]|TX|1625/9;1593/9;1544/9|
00000000|MMI|10.42|Antimicrobial susceptibility|C0427965|[fndg]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|Approximate|C0332232|[qlco]|["Approximate"-tx-5-"approximate"-adj-0]|TX|[1047/11],[1151/11]|
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[1715/9],[1865/9]|
00000000|MMI|10.42|Diagnostic Sensitivity|C1511883|[qnco]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|Increased Sensitivy|C2346484|[phpr]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-8-"obesity"-noun-0]|TX|[2021/7],[2031/7]|
00000000|MMI|10.42|Personality Sensitivity|C0312418|[menp]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|Recurrent cellulitis|C0742020|[dsyn]|["Cellulitis, recurrent"-tx-8-"recurrent cellulitis"-noun-0]|TX|[2041/20],[2328/20]|
00000000|MMI|10.42|Requirement|C1514873|[ftcn]|["Required"-tx-5-"Required"-verb-0]|TX|[1036/8],[1140/8]|
00000000|MMI|10.42|Signal Sensitivity|C2349185|[qlco]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|Statistical sensitivity|C0036667|[qnco]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-23-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|3731/6;185/6|
00000000|MMI|10.42|stimulus sensitivity|C1522640|[qlco]|["Sensitivity"-tx-5-"SENSITIVITY"-noun-0]|TX|[919/11],[967/11]|
00000000|MMI|9.90|Ulcer|C0041582|[dsyn]|["ULCER"-tx-15-"ulcer"-noun-0]|TX|3114/5|C23.550.891
00000000|MMI|9.76|Female|C0015780|[orga]|["FEMALE"-tx-8-"female"-noun-0]|TX|2309/6|x.x.x
00000000|MMI|9.76|Females|C0086287|[popg]|["female"-tx-8-"female"-noun-0]|TX|2309/6|x.x.x
00000000|MMI|9.76|Austria|C0004348|[geoa]|["AU"-tx-1-"Au"-noun-0]|TX|231/2|Z01.542.088
00000000|MMI|9.76|Communicable Diseases|C0009450|[dsyn]|["Infectious Disease"-tx-2-"infectious disease"-noun-0]|TX|769/18|C01.539.221
00000000|MMI|9.76|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-5-"TAB"-noun-0]|TX|1114/3|D26.255.830
00000000|MMI|9.73|Appointments|C0003629|[idcn]|["Appointment"-tx-5-"APPOINTMENT"-noun-0]|TX|1491/11|N04.452.095
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-8-"Infections"-noun-0]|TX|1888/10|C01.539
00000000|MMI|8.34|Work|C0043227|[ocac]|["Work"-tx-5-"WORK"-verb-0]|TX|1456/4|I03.946
00000000|MMI|7.70|Hospital admission|C0184666|[hlca]|["Admission"-tx-8-"Admission"-noun-0,"Admit"-tx-8-"ADMIT"-verb-0]|TX|1820/9;1709/5|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-18-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|3381/9;1875/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-18-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|3381/9;1875/10|
00000000|MMI|7.61|Emotional tenderness|C0684239|[menp]|["tenderness"-tx-15-"tenderness"-noun-0,"tenderness"-tx-10-"tenderness"-noun-0]|TX|3097/10;2736/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-18-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|3381/9;1875/10|
00000000|MMI|7.61|Sore to touch|C0234233|[sosy]|["TENDERNESS (NOS)"-tx-15-"tenderness"-noun-0,"TENDERNESS (NOS)"-tx-10-"tenderness"-noun-0]|TX|3097/10;2736/10|
00000000|MMI|7.53|Worse|C1457868|[fndg]|["Worse"-tx-10-"worse"-adj-0,"Worsening"-tx-8-"worsening"-verb-0]|TX|2756/5;2389/9|
00000000|MMI|7.53|Worsening pattern|C0332271|[qlco]|["worse"-tx-10-"worse"-adj-0,"Worsening"-tx-8-"worsening"-verb-0]|TX|2756/5;2389/9|
00000000|MMI|7.47|Present|C0150312|[qnco]|["Present"-tx-15-"present"-verb-0,"Present"-tx-8-"presents"-verb-0]|TX|3157/7;2366/8|
00000000|MMI|7.47|Presentation|C0449450|[idcn]|["Present"-tx-15-"present"-verb-0,"Present"-tx-8-"presents"-verb-0]|TX|3157/7;2366/8|
00000000|MMI|7.40|Clinic|C0442592|[hcro,mnob]|["Clinic"-tx-16-"clinic"-noun-0]|TX|[3234/6],[3246/6]|
00000000|MMI|7.29|Interaction|C1704675|[ftcn]|["Interaction"-tx-5-"INTERACTION"-noun-0]|TX|[1272/11],[1332/11]|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-21-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|3636/7;365/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-21-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|3636/7;365/7|
00000000|MMI|7.20|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-5-"Reason"-noun-0]|TX|[993/6],[1372/6]|
00000000|MMI|7.19|+5|C0728893|[qnco]|["+5"-tx-5-"5"-integer-0,"+5"-tx-2-"5"-fraction-0]|TX|1166/1;666/1|
00000000|MMI|7.19|>5|C0439084|[qnco]|[">5"-tx-5-"5"-integer-0,">5"-tx-2-"5"-fraction-0]|TX|1166/1;666/1|
00000000|MMI|7.15|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-5-"D/C"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|1468/3;336/3|
00000000|MMI|7.12|Every six hours|C0585325|[tmco]|["Q6H"-tx-14-"q6h"-noun-0,"Q6H"-tx-2-"Q6H"-noun-0]|TX|2969/3;645/3|
00000000|MMI|7.12|Switch Device Component|C1707719|[mnob]|["Switch"-tx-8-"switched"-verb-0]|TX|[2528/8],[2577/8]|
00000000|MMI|7.06|PVR gene|C1419141|[gngm]|["PVR"-tx-15-"PVR"-noun-0,"PVR"-tx-8-"PVRs"-noun-0]|TX|3036/3;2265/4|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|420/4;438/4|
00000000|MMI|7.02|Possible|C0332149|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|[897/8],[945/8]|
00000000|MMI|7.02|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|[897/8],[945/8]|
00000000|MMI|7.02|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-5-"POSSIBLE"-adj-0]|TX|[897/8],[945/8]|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|420/4;438/4|
00000000|MMI|7.00|week|C0439230|[tmco]|["WEEKS"-tx-17-"weeks"-noun-0,"WEEKS"-tx-2-"weeks"-noun-0]|TX|3348/5;723/5|
00000000|MMI|7.00|Alert|C3665546|[ftcn]|["Alert"-tx-5-"Alert"-noun-0,"Alert"-tx-3-"Alert"-adj-0]|TX|1204/5;823/5|
00000000|MMI|7.00|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-5-"Alert"-noun-0,"Alert"-tx-3-"Alert"-adj-0]|TX|1204/5;823/5|
00000000|MMI|7.00|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-5-"Alert"-noun-0,"ALERT"-tx-3-"Alert"-adj-0]|TX|1204/5;823/5|
00000000|MMI|6.98|Serious|C0205404|[qlco]|["Serious"-tx-5-"SERIOUS"-adj-0]|TX|[1264/7],[1324/7]|
00000000|MMI|6.97|4+ Answer to question|C3838679|[fndg]|["4+"-tx-21-"4"-fraction-0,"4+"-tx-20-"4"-fraction-0]|TX|3612/1;3554/1|
00000000|MMI|6.96|Primary operation|C0439631|[topp]|["Primary"-tx-18-"primary"-adj-0,"Primary"-tx-16-"primary"-adj-0]|TX|3479/7;3257/7|
00000000|MMI|6.96|True primary (qualifier value)|C0439612|[tmco]|["Primary"-tx-18-"primary"-adj-0,"Primary"-tx-16-"primary"-adj-0]|TX|3479/7;3257/7|
00000000|MMI|6.96|Intravascular systolic.tibial artery/Brachial artery:PresRto:Pt:Arterial system:Qn|C3888326|[clna]|["ABI"-tx-15-"ABI"-noun-0,"ABI"-tx-8-"ABI"-noun-0]|TX|3032/3;2261/3|
00000000|MMI|6.96|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-5-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|1195/2;525/2|
00000000|MMI|6.96|Milligram percent|C1960952|[qnco]|["mg %"-tx-5-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|1195/2;525/2|
00000000|MMI|6.96|mg/dL|C0439269|[qnco]|["mg%"-tx-5-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|1195/2;525/2|
00000000|MMI|6.90|HPS4 gene|C1423767|[gngm]|["LE"-tx-8-"LE"-noun-0]|TX|[2413/2],[2491/2]|
00000000|MMI|6.90|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-8-"LE"-noun-0]|TX|[2413/2],[2491/2]|
00000000|MMI|6.90|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-8-"LE"-noun-0]|TX|[2413/2],[2491/2]|
00000000|MMI|6.61|Woman|C0043210|[popg]|["female"-tx-8-"female"-noun-0]|TX|2309/6|M01.975
00000000|MMI|6.60|Tendon structure|C0039508|[bpoc]|["TENDON"-tx-15-"tendon"-noun-0]|TX|3123/6|A02.880
00000000|MMI|5.18|AMBP gene|C1412376|[gngm]|["UTI"-tx-8-"uti"-noun-0]|TX|2119/3|
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2184/10|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|1917/9|
00000000|MMI|5.18|Basal Diet|C2983588|[food]|["DIET"-tx-5-"DIET"-noun-0]|TX|1415/4|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-8-"Complications"-noun-0]|TX|1901/13|
00000000|MMI|5.18|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|1415/4|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|141/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|141/14|
00000000|MMI|5.18|Dosage|C0178602|[qnco]|["Doses"-tx-5-"Doses"-noun-0]|TX|1134/5|
00000000|MMI|5.18|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-8-"edema"-noun-0]|TX|1994/5|
00000000|MMI|5.18|Fluoroquinolone antibacterials, systemic|C3542473|[orch,phsu]|["Fluoroquinolones"-tx-8-"Fluoroquinolones"-noun-0]|TX|1677/16|
00000000|MMI|5.18|Fluoroquinolone antiinfectives, ophthalmologic|C3540047|[orch,phsu]|["Fluoroquinolones"-tx-8-"Fluoroquinolones"-noun-0]|TX|1677/16|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2184/10|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-8-"hypertension"-noun-0]|TX|1979/12|
00000000|MMI|5.18|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-2-"Instructions"-noun-0]|TX|673/12|
00000000|MMI|5.18|Instructions|C1442085|[idcn]|["Instructions"-tx-2-"Instructions"-noun-0]|TX|673/12|
00000000|MMI|5.18|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-2-"Instructions"-noun-0]|TX|673/12|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-8-"PROCEDURES"-noun-0]|TX|2199/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|1917/9|
00000000|MMI|5.18|Mandibular right first molar mesial prosthesis|C1553624|[medd]|["30pm"-tx-19-"30PM"-noun-0]|TX|3511/4|
00000000|MMI|5.18|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-10-"now"-adv-0]|TX|2773/3|
00000000|MMI|5.18|October|C3828732|[qlco]|["October"-tx-17-"October"-noun-0]|TX|3360/7|
00000000|MMI|5.18|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-8-"worsening"-verb-0]|TX|2389/9|
00000000|MMI|5.18|Peripheral edema|C0085649|[fndg]|["Peripheral oedema"-tx-8-"peripheral edema"-noun-0]|TX|2002/16|
00000000|MMI|5.18|Physiologic warmth|C0392197|[phsf]|["WARMTH"-tx-10-"warmth"-noun-0]|TX|2749/6|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2199/10|
00000000|MMI|5.18|Quinolone Antibacterial Agents|C1533693|[orch,phsu]|["QUINOLONES"-tx-8-"quinolones"-noun-0]|TX|1696/10|
00000000|MMI|5.18|Recurrent urinary tract infection|C0262655|[dsyn]|["Urinary tract infection"-tx-8-"urinary tract infection"-noun-0]|TX|2125/23|
00000000|MMI|5.18|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-5-"RETURN"-verb-0]|TX|1446/6|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-5-"("-noun-0]|TX|1502/1|
00000000|MMI|5.18|September|C3828193|[tmco]|["September"-tx-2-"September"-noun-0]|TX|735/9|
00000000|MMI|5.18|Social warmth|C0518610|[fndg]|["warmth"-tx-10-"warmth"-noun-0]|TX|2749/6|
00000000|MMI|5.18|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-5-"DIET"-noun-0]|TX|1415/4|
00000000|MMI|5.18|Started|C1272689|[qlco]|["Started"-tx-14-"started"-verb-0]|TX|2957/7|
00000000|MMI|5.18|Success|C0597535|[socb]|["Success"-tx-9-"success"-noun-0]|TX|2715/7|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-5-"("-noun-0]|TX|1502/1|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-8-"TREATMENTS/PROCEDURES"-noun-0]|TX|2217/21|
00000000|MMI|3.78|Entire left foot|C1279999|[bpoc]|["Left foot"-tx-15-"left foot"-noun-0]|TX|3133/4,3146/4|
00000000|MMI|3.78|Structure of left foot|C0230461|[bpoc]|["Left Foot"-tx-15-"left foot"-noun-0]|TX|3133/4,3146/4|
00000000|MMI|3.75|Additional comments|C1830770|[fndg]|["Additional comments"-tx-17-"ADDITIONAL COMMENTS"-noun-0]|TX|3276/19|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1753/9,1773/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1753/9,1773/9|
00000000|MMI|3.68|29+|C3843708|[fndg]|["29+"-tx-2-"29"-fraction-0]|TX|668/2|
00000000|MMI|3.68|Admission activity|C0809949|[hlca]|["Admission"-tx-8-"Admission"-noun-0]|TX|1820/9|
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|101/14|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|378/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|378/9|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|101/14|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|425/6|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-8-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1763/19|
00000000|MMI|3.65|mg/mg|C1319635|[qnco]|["mg/mg"-tx-2-"MG MG"-noun-0]|TX|558/2,581/2|
00000000|MMI|3.65|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|481/21|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|126/13|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-21-"ENTERED"-verb-0]|TX|3644/7|
00000000|MMI|3.63|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-8-"diabetes"-noun-0]|TX|1942/8|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|443/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|443/11|
00000000|MMI|3.63|Entire foot|C1281587|[bpoc]|["Foot"-tx-15-"foot"-noun-0]|TX|3146/4|
00000000|MMI|3.63|Feet, unit of measurement|C0347981|[qnco]|["foot"-tx-15-"foot"-noun-0]|TX|3146/4|
00000000|MMI|3.63|Foot British|C2348704|[qnco]|["foot"-tx-15-"foot"-noun-0]|TX|3146/4|
00000000|MMI|3.63|International Foot|C2346504|[qnco]|["Foot"-tx-15-"foot"-noun-0]|TX|3146/4|
00000000|MMI|3.63|Survey Foot|C2348613|[qnco]|["foot"-tx-15-"foot"-noun-0]|TX|3146/4|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-18-"PLAN"-noun-0]|TX|3405/4|
00000000|MMI|3.61|RNU1-4 gene|C1419475|[gngm]|["HSD2"-tx-15-"HSD2"-noun-0]|TX|2994/4|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-18-"PLAN"-noun-0]|TX|3405/4|
00000000|MMI|3.60|Study Day|C2826182|[tmco]|["DY"-tx-5-"dy"-noun-0]|TX|1443/2|
00000000|MMI|3.60|Dose number|C1115464|[qnco]|["Dose number"-tx-5-"Number Doses"-noun-0]|TX|1020/6,1030/5|
00000000|MMI|3.60|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-5-"Number Doses"-noun-0]|TX|1020/6,1030/5|
00000000|MMI|3.60|NEUROD1 wt Allele|C3273872|[gngm]|["NIDDM"-tx-8-"NIDDM"-noun-0]|TX|2320/5|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|249/7|
00000000|MMI|3.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|249/7|
00000000|MMI|3.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|249/7|
00000000|MMI|3.59|Deterioration of status|C1279889|[fndg]|["Worse"-tx-10-"worse"-adj-0]|TX|2756/5|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-23-"END"-noun-0]|TX|3714/3|
00000000|MMI|3.59|Floor (anatomic)|C3714591|[anst]|["Floor"-tx-13-"floor"-noun-0]|TX|2909/5|
00000000|MMI|3.59|Floor - story of building|C1547707|[geoa]|["Floor"-tx-13-"floor"-noun-0]|TX|2909/5|
00000000|MMI|3.59|GORAB gene|C1822658|[gngm]|["GO"-tx-16-"go"-verb-0]|TX|3178/2|
00000000|MMI|3.59|Improvement|C2986411|[cnce]|["Improvement"-tx-15-"improvement"-noun-0]|TX|3069/11|
00000000|MMI|3.59|Keflex|C0700517|[antb,orch]|["Keflex"-tx-8-"Keflex"-noun-0]|TX|2519/6|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-8-"Responsible"-adj-0]|TX|1784/11|
00000000|MMI|3.59|Spreading (qualifier value)|C0332261|[qlco]|["Spreading"-tx-10-"spreading"-verb-0]|TX|2777/9|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-23-"END"-noun-0]|TX|3714/3|
00000000|MMI|3.59|Ulceration|C3887532|[patf]|["ULCER"-tx-15-"ulcer"-noun-0]|TX|3114/5|
00000000|MMI|3.59|floor (object)|C0016249|[mnob]|["Floor"-tx-13-"floor"-noun-0]|TX|2909/5|
00000000|MMI|3.59|Today|C0310367|[antb,orch]|["Today"-tx-2-"Today"-noun-0]|TX|658/5|
00000000|MMI|3.59|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-2-"Today"-noun-0]|TX|658/5|
00000000|MMI|3.59|heparin, porcine|C0770546|[bacs,orch,phsu]|["HEPARIN"-tx-2-"HEPARIN"-noun-0]|TX|590/7|
00000000|MMI|3.58|Count of entities|C0449788|[qnco]|["Number"-tx-5-"Number"-noun-0]|TX|1124/6|
00000000|MMI|3.58|Numbers|C0237753|[qnco]|["*Number"-tx-5-"Number"-noun-0]|TX|1124/6|
00000000|MMI|3.58|Day 3|C3842675|[fndg]|["Day 3"-tx-8-"3 days"-noun-0]|TX|2382/6|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|305/10|
00000000|MMI|3.57|Negation|C1518422|[ftcn]|["Not"-tx-8-"NOT"-adv-0]|TX|2241/3|
00000000|MMI|3.57|R prime|C2603358|[clna]|["R'"-tx-8-"R"-noun-0]|TX|2250/1|
00000000|MMI|3.57|Right|C0205090|[spco]|["R-"-tx-8-"R"-noun-0]|TX|2250/1|
00000000|MMI|3.55|Approval (document)|C2346845|[inpr]|["Approval"-tx-2-"approval"-noun-0]|TX|788/8|
00000000|MMI|3.55|Approved|C0205540|[qlco]|["Approval"-tx-2-"approval"-noun-0]|TX|788/8|
00000000|MMI|3.55|Letter of Authorization|C2697909|[rnlw]|["Approval"-tx-2-"approval"-noun-0]|TX|788/8|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|349/4|
00000000|MMI|3.54|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-8-"RESUME"-noun-0]|TX|2276/6|
00000000|MMI|3.54|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-8-"RESUME"-noun-0]|TX|2276/6|
00000000|MMI|3.54|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-8-"RESUME"-noun-0]|TX|2276/6|
00000000|MMI|3.54|Asymptomatic|C0231221|[fndg]|["Asymptomatic"-tx-11-"asymptomatic"-adj-1]|TX|2824/12|
00000000|MMI|3.53|Lateral to the left|C0450414|[spco]|["Left lateral"-tx-15-"left lateral"-adj-0]|TX|3133/12|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-8-"Causing"-adj-0]|TX|1812/7|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|374/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|374/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-21-"dictated"-adj-0]|TX|3627/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-21-"dictated"-adj-0]|TX|3627/8|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-2-"Full"-adj-0]|TX|433/4|
00000000|MMI|3.48|Gait normal|C0231683|[fndg]|["Normal"-tx-15-"normal"-adj-0]|TX|3010/6|
00000000|MMI|3.48|Lateral|C0205093|[spco]|["LATERAL"-tx-15-"lateral"-adj-0]|TX|3138/7|
00000000|MMI|3.48|Less Than|C0439092|[qnco]|["Less"-tx-15-"less"-adv-0]|TX|3083/4|
00000000|MMI|3.48|Mean Percent of Normal|C2347086|[qnco]|["% Normal"-tx-15-"normal"-adj-0]|TX|3010/6|
00000000|MMI|3.48|Normal|C0205307|[qlco]|["NORMAL"-tx-15-"normal"-adj-0]|TX|3010/6|
00000000|MMI|3.48|Percent normal|C0439166|[qnco]|["% normal"-tx-15-"normal"-adj-0]|TX|3010/6|
00000000|MMI|3.48|Smaller|C0547044|[qlco]|["Less"-tx-15-"less"-adv-0]|TX|3083/4|
00000000|MMI|3.48|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|E02
00000000|MMI|3.48|Treating|C1522326|[ftcn]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-8-"Treatment"-noun-0]|TX|1927/9|
00000000|MMI|3.48|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-8-"h/o"-noun-0]|TX|2316/3|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-8-"Treatment"-noun-0]|TX|1927/9|
00000000|MMI|3.47|Imipenem 500 MG|C4060343|[clnd]|["Imipenem 500 MG"-tx-2-"IMIPENEM 500 MG"-noun-0]|TX|615/8,635/6|
00000000|MMI|3.47|Cilastatin 500 MG|C4060344|[clnd]|["Cilastatin 500 MG"-tx-2-"CILASTATIN 500 MG"-noun-0]|TX|624/17|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|95/3|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-18-"Stable"-adj-0]|TX|3392/6|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-18-"Stable"-adj-0]|TX|3392/6|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|1753/9|
00000000|MMI|3.46|0/5|C0444499|[qnco]|["0/5"-tx-5-"0 5"-integer-0]|TX|1096/1,1106/1|
00000000|MMI|3.46|+2|C0740116|[qnco]|["+2"-tx-1-"2"-fraction-0]|TX|117/1|
00000000|MMI|3.46|2+|C3833492|[fndg]|["2+"-tx-1-"2"-fraction-0]|TX|117/1|
00000000|MMI|3.46|2+ Score|C2827735|[qnco]|["2+"-tx-1-"2"-fraction-0]|TX|117/1|
00000000|MMI|3.46|2+ Score, WHO|C2981700|[clas]|["2+"-tx-1-"2"-fraction-0]|TX|117/1|
00000000|MMI|3.46|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-5-"ADA"-noun-0]|TX|1429/3|
00000000|MMI|3.46|CA8 gene|C1413051|[gngm]|["CALS"-tx-5-"cals"-noun-0]|TX|1438/4|
00000000|MMI|3.46|Clipperton Island|C4050020|[geoa]|["CP"-tx-12-"CP"-noun-0]|TX|2860/2|
00000000|MMI|3.46|Diarrhea Adverse Event|C1963091|[fndg]|["Diarrhea"-tx-12-"diarrhea"-noun-1]|TX|2875/8|
00000000|MMI|3.46|Genus Ada|C1060325|[plnt]|["Ada"-tx-5-"ADA"-noun-0]|TX|1429/3|
00000000|MMI|3.46|Home environment|C0442519|[cnce]|["house"-tx-5-"House"-noun-0]|TX|1421/5|
00000000|MMI|3.46|House (environment)|C2003847|[mnob]|["House"-tx-5-"House"-noun-0]|TX|1421/5|
00000000|MMI|3.46|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-5-"cals"-noun-0]|TX|1438/4|
00000000|MMI|3.46|kilocalorie|C0439259|[qnco]|["Cal"-tx-5-"cals"-noun-0]|TX|1438/4|
00000000|MMI|3.46|Lisinopril 20 MG|C0987219|[clnd]|["Lisinopril 20 MG"-tx-5-"LISINOPRIL 20 MG"-noun-0]|TX|1065/16|
00000000|MMI|3.46|30%|C3842588|[fndg]|["30%"-tx-8-"30"-fraction-0]|TX|1619/2|
00000000|MMI|3.46|CDR2 gene|C1413296|[gngm]|["Yo"-tx-8-"yo"-noun-0]|TX|2306/2|
00000000|MMI|3.46|Female Phenotype|C1705498|[qlco]|["Female"-tx-8-"female"-noun-0]|TX|2309/6|
00000000|MMI|3.46|Female, Self-Report|C1705497|[qlco]|["Female"-tx-8-"female"-noun-0]|TX|2309/6|
00000000|MMI|3.45|metric ton|C0439216|[qnco]|["tons"-tx-1-"Tons"-noun-0]|TX|234/4|
00000000|MMI|3.45|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-13-"ED"-noun-0]|TX|2899/2|
00000000|MMI|3.45|Entire tendon|C1280538|[bpoc]|["Tendon"-tx-15-"tendon"-noun-0]|TX|3123/6|
00000000|MMI|3.45|Infectious Disease Pathway|C3714515|[ftcn]|["Infectious Disease"-tx-2-"infectious disease"-noun-0]|TX|769/18|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-8-"Study"-noun-0]|TX|1802/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-8-"Study"-noun-0]|TX|1802/5|
00000000|MMI|3.45|0%|C3842591|[fndg]|["0%"-tx-5-"0"-integer-0]|TX|1096/1|
00000000|MMI|3.45|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-5-"TAB"-noun-0]|TX|1114/3|
00000000|MMI|3.44|1800s|C0681738|[tmco]|["1800s"-tx-5-"1800"-integer-0]|TX|1433/4|
00000000|MMI|3.44|Hospital course|C0489547|[fndg]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-1]|TX|2286/15|
00000000|MMI|3.44|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-0]|TX|2286/15|
00000000|MMI|3.43|3 Days|C1442459|[tmco]|["3 Days"-tx-9-"3 days"-noun-0]|TX|2659/6|
00000000|MMI|3.43|Left|C0205091|[spco]|["LEFT"-tx-8-"left"-adj-0]|TX|2486/4|
00000000|MMI|3.43|Left sided|C0443246|[spco]|["Left"-tx-8-"left"-adj-0]|TX|2486/4|
00000000|MMI|3.43|Receive|C1514756|[qlco]|["RECEIVED"-tx-2-"received"-adj-0]|TX|760/8|
00000000|MMI|3.43|Table Cell Horizontal Align - left|C1552822|[ftcn]|["left"-tx-8-"left"-adj-0]|TX|2486/4|
00000000|MMI|3.43|VARIOUS DRUG CLASSES IN ATC|C3540763|[phsu]|["VARIOUS"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|Various patch test substance|C0440102|[irda]|["Various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various allergen extracts|C3540765|[imft,phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various antiinfectives and antiseptics for local oral treatment|C3540008|[phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various antiseptic throat preparations|C3540766|[phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various other agents for local oral treatment in ATC|C3540762|[phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various other intestinal adsorbents in ATC|C3540769|[phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.43|various other nasal preparations in ATC|C3540761|[phsu]|["various"-tx-8-"various"-adj-0]|TX|2462/7|
00000000|MMI|3.42|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-8-"BRIEF"-adj-0]|TX|2270/5|
00000000|MMI|3.42|Brief|C1879313|[tmco]|["Brief"